NDRA · Categories · Form 4

NDRA - SEC Form 4 insider transactions

ENDRA Life Sciences Inc. (NDRA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NDRA

• 90d
  Chief Executive Officer Tokman Alexander Y was granted 26,921 shares, increasing direct ownership by 36% to 101,926 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 90d
  Chief Financial Officer Jacroux Richard was granted 13,461 shares, increasing direct ownership by 67% to 33,461 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 131d
  Director Digiandomenico Anthony was granted 60,324 shares, increasing direct ownership by 79% to 136,589 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 131d
  Director Harsh Michael was granted 60,324 shares, increasing direct ownership by 1,120% to 65,710 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 131d
  Chief Financial Officer Jacroux Richard was granted 20,000 shares (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 131d
  Director Basenese Lou was granted 60,324 shares, increasing direct ownership by 1,120% to 65,709 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 131d
  Chief Executive Officer Tokman Alexander Y was granted 75,000 shares, increasing direct ownership by 1,500,000% to 75,005 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 230d
  Director Digiandomenico Anthony was granted 70,822 shares, increasing direct ownership by 1,301% to 76,265 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 337d
  Director Basenese Lou was granted 5,384 shares, increasing direct ownership by 538,400% to 5,385 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 337d
  Director Harsh Michael was granted 5,384 shares, increasing direct ownership by 269,200% to 5,386 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 337d
  Director Digiandomenico Anthony was granted 5,384 shares, increasing direct ownership by 9,125% to 5,443 units (SEC Form 4)

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 831d
  SEC Form 4 filed by Harsh Michael

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 831d
  SEC Form 4 filed by Digiandomenico Anthony

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 831d
  SEC Form 4 filed by Basenese Lou

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 831d
  SEC Form 4 filed by Tokman Alexander Y

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1108d
  SEC Form 4 filed by Thornton Michael Milos

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1127d
  SEC Form 4 filed by Digiandomenico Anthony

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1217d
  SEC Form 4 filed by Basenese Lou

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1217d
  SEC Form 4 filed by Tokman Alexander Y

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1217d
  SEC Form 4 filed by Digiandomenico Anthony

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1217d
  SEC Form 4 filed by Pestrikova Irina

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1217d
  SEC Form 4 filed by Harsh Michael

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1217d
  SEC Form 4 filed by Michelon Francois Roger

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1217d
  SEC Form 4 filed by Thornton Michael Milos

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1268d
  SEC Form 4: Thornton Michael Milos bought $5,100 worth of shares (1,500 units at $3.40), increasing direct ownership by 9% to 19,139 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1283d
  SEC Form 4: Tokman Alexander Y bought $1,700 worth of shares (10,000 units at $0.17), increasing direct ownership by 7% to 162,857 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1379d
  SEC Form 4: Thornton Michael Milos bought $5,400 worth of shares (20,000 units at $0.27), increasing direct ownership by 6% to 352,775 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1379d
  SEC Form 4: Tokman Alexander Y bought $5,200 worth of shares (20,000 units at $0.26), increasing direct ownership by 15% to 152,857 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1464d
  SEC Form 4: Thornton Michael Milos bought $5,250 worth of shares (25,000 units at $0.21), increasing direct ownership by 8% to 332,775 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1472d
  SEC Form 4: Thornton Michael Milos bought $5,500 worth of shares (25,000 units at $0.22), increasing direct ownership by 9% to 307,775 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1476d
  SEC Form 4: Michelon Francois Roger bought $969 worth of shares (5,100 units at $0.19), increasing direct ownership by 6% to 97,191 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1478d
  SEC Form 4: Tokman Alexander Y bought $19,630 worth of shares (100,000 units at $0.20), increasing direct ownership by 304% to 132,857 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1526d
  SEC Form 4 filed by Maloberti Renaud Bertrand

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1526d
  SEC Form 4 filed by Thornton Michael Milos

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1526d
  SEC Form 4 filed by Digiandomenico Anthony

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1526d
  SEC Form 4 filed by Tokman Alexander Y

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1526d
  SEC Form 4 filed by Pestrikova Irina

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1526d
  SEC Form 4 filed by Harsh Michael

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1526d
  SEC Form 4 filed by Michelon Francois Roger

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1526d
  SEC Form 4 filed by Basenese Lou

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1611d
  SEC Form 4 filed by Tokman Alexander Y

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1611d
  SEC Form 4 filed by Digiandomenico Anthony

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1611d
  SEC Form 4 filed by Harsh Michael

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1611d
  SEC Form 4 filed by Basenese Lou

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1715d
  SEC Form 4: Thornton Michael Milos was granted 22,815 units of Common Stock, increasing direct ownership by 8% to 316,525 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1741d
  SEC Form 4: Basenese Lou sold $91,600 worth of Common Stock (50,000 units at $1.83), decreasing direct ownership by 50% to 49,068 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1807d
  SEC Form 4 filed by Pestrikova Irina

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1860d
  SEC Form 4: Thornton Michael Milos was granted 22,815 units of Common Stock, increasing direct ownership by 8% to 316,525 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1883d
  SEC Form 4 filed by Y Alexander Tokman

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1883d
  SEC Form 4 filed by Michael Harsh

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1883d
  SEC Form 4 filed by Anthony Digiandomenico

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1883d
  SEC Form 4 filed by Lou Basenese

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1883d
  SEC Form 4 filed by Bertrand Renaud Maloberti

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1883d
  SEC Form 4 filed by R. David Wells

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1883d
  SEC Form 4: Milos Michael Thornton sold $82,388 worth of Common Stock (33,750 units at $2.44), decreasing direct ownership by 11% to 259,960 units

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1883d
  SEC Form 4 filed by Roger Francois Michelon

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1896d
  SEC Form 4 filed by Lou Basenese

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)
• 1896d
  SEC Form 4 filed by Anthony Digiandomenico

  4 - ENDRA Life Sciences Inc. (0001681682) (Issuer)

Other NDRA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends